Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.590 |
FusionGene
|
disease |
ORPHANET |
|
|
|
myeloblastosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
Matched normal/tumor DNA pairs from patients with sporadic and hereditary (FAP = familial adenomatous polyposis) colorectal carcinoma were examined for tumor-specific allele loss on chromosome 6 using cDNA probes for the avian myeloblastosis viral oncogene homologue (MYB on 6q22-q23), the estrogen receptor (ESR on 6q24-q27), and for the alpha polypeptide of human chorionic gonadotropin (CGA on 6q14-q21).
|
1332582 |
1992 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We found that the tumor samples always expressed higher levels of full length Myb protein than the normal tissue.
|
1445802 |
1992 |
leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis.
|
1560675 |
1992 |
Childhood Leukemia
|
0.080 |
AlteredExpression
|
disease |
BEFREE |
Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis.
|
1560675 |
1992 |
Acute lymphocytic leukemia
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Immunofluorescent analyses revealed expression of c-myb protein in the nucleus of ALL (5/7) and AML (9/9) with a good correlation of c-myb-positive cells and with the number of proliferating (Ki67-positive) blast cells.
|
1560675 |
1992 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Several of the tumors that exhibit 6q- abnormalities have also been found to express high levels of c-myb and, in some cases, amplification of the c-myb gene, leading to the suggestion that this gene could lie in proximity to the deletions observed in these tumors.
|
1630821 |
1992 |
Hematopoietic Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
We then examined the occurrence of abnormalities near the c-myb gene in several hematopoietic tumor cell lines containing well-characterized 6q- abnormalities.
|
1630821 |
1992 |
leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Of the 45 patient samples analyzed, only three (one B-prolymphocytic and two acute T-lymphoblastic leukemias) contained detectable amounts of myc or myb protein.
|
2144164 |
1990 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the present study we have analysed in breast cancer the c-myb gene with the aim to determine its involvement in tumour progression.
|
2181374 |
1990 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the present study we have analysed in breast cancer the c-myb gene with the aim to determine its involvement in tumour progression.
|
2181374 |
1990 |
Tumor Progression
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
In the present study we have analysed in breast cancer the c-myb gene with the aim to determine its involvement in tumour progression.
|
2181374 |
1990 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Rearrangements, deletions, or amplifications were absent in these tumor DNAs, thereby indicating that the del(6q) breakpoint in these T-cell malignancies was located outside of the c-myb gene.
|
2204478 |
1990 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Rearrangements, deletions, or amplifications were absent in these tumor DNAs, thereby indicating that the del(6q) breakpoint in these T-cell malignancies was located outside of the c-myb gene.
|
2204478 |
1990 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The human c-myb gene which encodes a DNA binding protein and which is rarely amplified in neoplastic cells was found to be altered in four human glioblastoma cell lines.
|
2354420 |
1990 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The human c-myb gene which encodes a DNA binding protein and which is rarely amplified in neoplastic cells was found to be altered in four human glioblastoma cell lines.
|
2354420 |
1990 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The human c-myb gene which encodes a DNA binding protein and which is rarely amplified in neoplastic cells was found to be altered in four human glioblastoma cell lines.
|
2354420 |
1990 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
The human c-myb gene which encodes a DNA binding protein and which is rarely amplified in neoplastic cells was found to be altered in four human glioblastoma cell lines.
|
2354420 |
1990 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Deletions and translocations involving this region of the long arm of chromosome 6 occur frequently in human malignant melanoma, and there are anecdotal reports of MYB gene rearrangements in this cancer.
|
2487149 |
1989 |
Primary malignant neoplasm
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Deletions and translocations involving this region of the long arm of chromosome 6 occur frequently in human malignant melanoma, and there are anecdotal reports of MYB gene rearrangements in this cancer.
|
2487149 |
1989 |
melanoma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Also, two melanomas (containing alterations in band 6q13) also demonstrated by PFGE a unique restriction fragment for the MYB gene.
|
2487149 |
1989 |
Epithelioma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The presence of myb transcripts in SCLC suggests that the myb gene may have a specific role in the initiation or maintenance of an important human epithelial tumor.
|
2578097 |
1985 |
Small cell carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
The presence of myb transcripts in SCLC suggests that the myb gene may have a specific role in the initiation or maintenance of an important human epithelial tumor.
|
2578097 |
1985 |
Malignant neoplasm of breast
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Five proto-oncogenes were found to be occasionally amplified in primary breast cancers: c-ERBB-2 (11%), c-MYB (3%), c-RAS-Ki (3%), INT-2 (4%) and c-MYC (6%).
|
2915899 |
1989 |
Acute leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Studies of the human c-myb gene and its product in human acute leukemias.
|
3014652 |
1986 |